Michelle Kenyon

2.7k total citations
63 papers, 1.3k citations indexed

About

Michelle Kenyon is a scholar working on Hematology, Oncology and Cancer Research. According to data from OpenAlex, Michelle Kenyon has authored 63 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 16 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Michelle Kenyon's work include Hematopoietic Stem Cell Transplantation (22 papers), Acute Myeloid Leukemia Research (15 papers) and Carcinogens and Genotoxicity Assessment (14 papers). Michelle Kenyon is often cited by papers focused on Hematopoietic Stem Cell Transplantation (22 papers), Acute Myeloid Leukemia Research (15 papers) and Carcinogens and Genotoxicity Assessment (14 papers). Michelle Kenyon collaborates with scholars based in United Kingdom, United States and Switzerland. Michelle Kenyon's co-authors include Antonio Pagliuca, Aloysius Ho, Ghulam J. Mufti, Krista L. Dobo, Stephen Devereux, Judith Marsh, Jane E. Parker, Aleksandar Mijović, Susanne Glowienke and Robin Ireland and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Medicinal Chemistry.

In The Last Decade

Michelle Kenyon

58 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle Kenyon United Kingdom	21	570	279	234	191	190	63	1.3k
Aram Oganesian United States	20	375 0.7×	111 0.4×	728 3.1×	98 0.5×	27 0.1×	56	1.2k
Julie Bullock United States	17	356 0.6×	69 0.2×	467 2.0×	89 0.5×	19 0.1×	26	1.6k
Justin Taylor United States	18	362 0.6×	172 0.6×	708 3.0×	144 0.8×	148 0.8×	79	1.7k
Rashid Mir India	25	95 0.2×	542 1.9×	1.0k 4.4×	95 0.5×	33 0.2×	139	2.1k
Oliver Scherf‐Clavel Germany	16	94 0.2×	71 0.3×	176 0.8×	35 0.2×	80 0.4×	61	771
David de Graaf United States	11	98 0.2×	38 0.1×	394 1.7×	40 0.2×	60 0.3×	15	1.0k
Felix Huth Switzerland	17	73 0.1×	41 0.1×	163 0.7×	106 0.6×	139 0.7×	60	977
Dennis C. Mays United States	21	69 0.1×	128 0.5×	396 1.7×	274 1.4×	22 0.1×	56	1.4k
Alan B. Weitberg United States	22	69 0.1×	348 1.2×	627 2.7×	117 0.6×	125 0.7×	55	1.9k
Alain Deroussent France	21	357 0.6×	60 0.2×	529 2.3×	139 0.7×	8 0.0×	47	1.5k

Countries citing papers authored by Michelle Kenyon

Since Specialization

Citations

This map shows the geographic impact of Michelle Kenyon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Kenyon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Kenyon more than expected).

Fields of papers citing papers by Michelle Kenyon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Kenyon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Kenyon. The network helps show where Michelle Kenyon may publish in the future.

Co-authorship network of co-authors of Michelle Kenyon

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Kenyon. A scholar is included among the top collaborators of Michelle Kenyon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Kenyon. Michelle Kenyon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Greco, Raffaella, Annalisa Ruggeri, Donal P. McLornan, et al.. (2025). Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations. Bone Marrow Transplantation. 60(11). 1499–1525.

Jessop, Helen, Jörg Henes, Anna Carmagnola, et al.. (2024). Nutritional aspects in autoimmune diseases undergoing hematopoietic stem cell transplantation: overview and recommendations on behalf of the EBMT ADWP and Nurses Group. Frontiers in Nutrition. 11. 1394518–1394518.

Bercu, Joel P., Olivier Dirat, Krista L. Dobo, et al.. (2024). N-Nitrosamine drug substance related impurities (NDSRIs) – A proposal for the addition of subcategories to carcinogenic potency categorization approach categories 1 and 2 for NDSRIs with a molecular weight > 200 Da. Regulatory Toxicology and Pharmacology. 154. 105704–105704. 7 indexed citations

Yu, Shu, J. Christopher McWilliams, Olivier Dirat, et al.. (2024). A Kinetic Model for Assessing Potential Nitrosamine Carcinogenicity. Chemical Research in Toxicology. 37(8). 1382–1393. 5 indexed citations

Kenyon, Michelle, Sarah Liptrott, Daphna Hutt, et al.. (2024). Nurses’ reported training needs for advanced cell therapies: a survey on behalf of the Nurses Group of the EBMT. PubMed. 6(4). 104–113.

Avenoso, Daniele, Stella Bouziana, Francesco Dazzi, et al.. (2024). HAPLOIDENTICAL TRANSPLANT WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROMES PATIENTS: THE ROLE OF PREVIOUS LINES OF THERAPY.. Mediterranean Journal of Hematology and Infectious Diseases. 16(1). e2024002–e2024002. 1 indexed citations

Foster, Robert S., Alessandro Brigo, Wolfgang Muster, et al.. (2023). Assessing the utility of common arguments used in expert review of in silico predictions as part of ICH M7 assessments. Regulatory Toxicology and Pharmacology. 144. 105490–105490. 3 indexed citations

Yakoub‐Agha, Ibrahim, Raffaella Greco, Francesco Onida, et al.. (2023). Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy. Bone Marrow Transplantation. 58(6). 696–700. 10 indexed citations

Dobo, Krista L., Michelle Kenyon, Olivier Dirat, et al.. (2022). Practical and Science-Based Strategy for Establishing Acceptable Intakes for Drug Product N-Nitrosamine Impurities. Chemical Research in Toxicology. 35(3). 475–489. 62 indexed citations

10.

Ponting, David J., Krista L. Dobo, Michelle Kenyon, & Amit S. Kalgutkar. (2022). Strategies for Assessing Acceptable Intakes for Novel N-Nitrosamines Derived from Active Pharmaceutical Ingredients. Journal of Medicinal Chemistry. 65(23). 15584–15607. 27 indexed citations

11.

Eeltink, Corien, Jacqui Stringer, Paul Bosman, et al.. (2022). Sexual function of adult long-term survivors and their partners after allogeneic hematopoietic cell transplantation in Europe (S-FAST): a study from the Transplant Complications Working Party and Nurses Group of the EBMT. Bone Marrow Transplantation. 58(2). 195–202. 4 indexed citations

12.

Ellard, Rose, Michelle Kenyon, Daphna Hutt, et al.. (2022). The EBMT Immune Effector Cell Nursing Guidelines on CAR-T Therapy: A Framework for Patient Care and Managing Common Toxicities. SHILAP Revista de lepidopterología. 4(3). 75–88. 13 indexed citations

13.

Kenyon, Michelle, Rose Ellard, Katerina Bakunina, et al.. (2021). The 47th Annual Meeting of the European Society for Blood and Marrow Transplantation: Nurses Group – Poster Sessions (NP001 – NP028). Bone Marrow Transplantation. 56(S1). 344–362.

14.

Bercu, Joel P., George E. Johnson, Andreas Czich, et al.. (2021). Use of less-than-lifetime (LTL) durational limits for nitrosamines: Case study of N-Nitrosodiethylamine (NDEA). Regulatory Toxicology and Pharmacology. 123. 104926–104926. 20 indexed citations

15.

Graham, Jessica, Mark W. Powley, Susanne Glowienke, et al.. (2021). Calculating qualified non-mutagenic impurity levels: Harmonization of approaches. Regulatory Toxicology and Pharmacology. 126. 105023–105023. 7 indexed citations

16.

Dignan, Fiona L., Angela Hamblin, Jungwha Lee, et al.. (2020). Survivorship care for allogeneic transplant patients in the UK NHS: changes centre practice, impact of health service policy and JACIE accreditation over 5 years. Bone Marrow Transplantation. 56(3). 673–678. 7 indexed citations

17.

Sheth, Vipul, Vanessa E. Kennedy, Hugues de Lavallade, et al.. (2019). Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center Experience. Frontiers in Oncology. 9. 623–623. 3 indexed citations

18.

Greene, Nigel, Krista L. Dobo, Michelle Kenyon, et al.. (2015). A practical application of two in silico systems for identification of potentially mutagenic impurities. Regulatory Toxicology and Pharmacology. 72(2). 335–349. 32 indexed citations

19.

Lim, Zi Yi, Pramila Krishnamurthy, Victoria Potter, et al.. (2011). Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis. Leukemia Research. 35(8). 998–1000. 1 indexed citations

20.

Lim, Z Y, Valeria Fiaccadori, Shreyans Gandhi, et al.. (2009). Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation. Leukemia Research. 34(6). 723–727. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact